The administration of tranexamic acid (TXA)  a drug used for the treatment of blood loss from postpartum bleeding and major trauma  improved functional outcome in patients with stroke due to intracerebral hemorrhage  according to an international trial published in the journal The Lancet and presented at the 4th European Stroke Conference in Gothenburg  Sweden